Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seppo W Langer

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Plos One|April 29, 2020
Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients - initial observationsLotte Nygård, Lise B Ahlborn, Gitte F Persson, et al.
Lung Cancer (Amsterdam, Netherlands)|June 29, 2020
Early initiated postoperative rehabilitation enhances quality of life in patients with operable lung cancer: Secondary outcomes from a randomized trialMaja Schick Sommer, Jette Vibe-Petersen, Maja Bohlbro Stærkind, et al.
Acta Oncologica (Stockholm, Sweden)|May 17, 2023
Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasmsGitte Dam, Henning Grønbæk, Anna Sundlöv, et al.
Plos One|December 14, 2020
PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3Abir Salwa Ali, Seppo W Langer, Birgitte Federspiel, et al.
Plos One|November 8, 2017
Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinomaAbir Salwa Ali, Malin Grönberg, Birgitte Federspiel, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
Early initiated postoperative rehabilitation reduces fatigue in patients with operable lung cancer: A randomized trialMorten Quist, Maja Schick Sommer, Jette Vibe-Petersen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 19, 2022
First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using <sup>18</sup>F-labeled Active-Site Inhibited Factor VII (<sup>18</sup>F-ASIS): Potential as Companion DiagnosticMathias Loft, Camilla Christensen, Malene M Clausen, et al.
Journal of Neuroendocrinology|March 26, 2021
Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasmsHans-Christian Pommergaard, Kirstine Nielsen, Halfdan Sorbye, et al.
Neuroendocrinology|October 1, 2020
A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical CorrelationsHege Elvebakken, Aurel Perren, Jean-Yves Scoazec, et al.
British Journal of Cancer|July 14, 2025
Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 studyHalfdan Sorbye, Geir Olav Hjortland, Lene Weber Vestermark, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Plos One|April 29, 2020
Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients - initial observationsLotte Nygård, Lise B Ahlborn, Gitte F Persson, et al.
Lung Cancer (Amsterdam, Netherlands)|June 29, 2020
Early initiated postoperative rehabilitation enhances quality of life in patients with operable lung cancer: Secondary outcomes from a randomized trialMaja Schick Sommer, Jette Vibe-Petersen, Maja Bohlbro Stærkind, et al.
Acta Oncologica (Stockholm, Sweden)|May 17, 2023
Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasmsGitte Dam, Henning Grønbæk, Anna Sundlöv, et al.
Plos One|December 14, 2020
PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3Abir Salwa Ali, Seppo W Langer, Birgitte Federspiel, et al.
Plos One|November 8, 2017
Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinomaAbir Salwa Ali, Malin Grönberg, Birgitte Federspiel, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
Early initiated postoperative rehabilitation reduces fatigue in patients with operable lung cancer: A randomized trialMorten Quist, Maja Schick Sommer, Jette Vibe-Petersen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 19, 2022
First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using <sup>18</sup>F-labeled Active-Site Inhibited Factor VII (<sup>18</sup>F-ASIS): Potential as Companion DiagnosticMathias Loft, Camilla Christensen, Malene M Clausen, et al.
Journal of Neuroendocrinology|March 26, 2021
Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasmsHans-Christian Pommergaard, Kirstine Nielsen, Halfdan Sorbye, et al.
Neuroendocrinology|October 1, 2020
A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical CorrelationsHege Elvebakken, Aurel Perren, Jean-Yves Scoazec, et al.
British Journal of Cancer|July 14, 2025
Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 studyHalfdan Sorbye, Geir Olav Hjortland, Lene Weber Vestermark, et al.
Pageof 12